ETFS SP (Australia) Market Value

CURE Etf   52.42  0.43  0.81%   
ETFS SP's market value is the price at which a share of ETFS SP trades on a public exchange. It measures the collective expectations of ETFS SP Biotech investors about its performance. ETFS SP is selling for under 52.42 as of the 2nd of December 2024; that is 0.81 percent decrease since the beginning of the trading day. The etf's last reported lowest price was 52.35.
With this module, you can estimate the performance of a buy and hold strategy of ETFS SP Biotech and determine expected loss or profit from investing in ETFS SP over a given investment horizon. Check out ETFS SP Correlation, ETFS SP Volatility and ETFS SP Alpha and Beta module to complement your research on ETFS SP.
Symbol

Please note, there is a significant difference between ETFS SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if ETFS SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ETFS SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ETFS SP 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ETFS SP's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ETFS SP.
0.00
06/05/2024
No Change 0.00  0.0 
In 5 months and 30 days
12/02/2024
0.00
If you would invest  0.00  in ETFS SP on June 5, 2024 and sell it all today you would earn a total of 0.00 from holding ETFS SP Biotech or generate 0.0% return on investment in ETFS SP over 180 days. ETFS SP is related to or competes with Betashares Asia, BetaShares Australia, Australian High, and Vanguard Australian. ETFS SP is entity of Australia. It is traded as Etf on AU exchange. More

ETFS SP Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ETFS SP's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ETFS SP Biotech upside and downside potential and time the market with a certain degree of confidence.

ETFS SP Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for ETFS SP's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ETFS SP's standard deviation. In reality, there are many statistical measures that can use ETFS SP historical prices to predict the future ETFS SP's volatility.
Hype
Prediction
LowEstimatedHigh
50.8452.4354.02
Details
Intrinsic
Valuation
LowRealHigh
50.5152.1053.69
Details
Naive
Forecast
LowNextHigh
52.9654.5556.14
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
48.0851.0153.95
Details

ETFS SP Biotech Backtested Returns

Currently, ETFS SP Biotech is very steady. ETFS SP Biotech secures Sharpe Ratio (or Efficiency) of 0.0348, which denotes the etf had a 0.0348% return per unit of return volatility over the last 3 months. We have found twenty-nine technical indicators for ETFS SP Biotech, which you can use to evaluate the volatility of the entity. Please confirm ETFS SP's mean deviation of 1.12, and Downside Deviation of 1.68 to check if the risk estimate we provide is consistent with the expected return of 0.0554%. The etf shows a Beta (market volatility) of 0.65, which means possible diversification benefits within a given portfolio. As returns on the market increase, ETFS SP's returns are expected to increase less than the market. However, during the bear market, the loss of holding ETFS SP is expected to be smaller as well.

Auto-correlation

    
  0.14  

Insignificant predictability

ETFS SP Biotech has insignificant predictability. Overlapping area represents the amount of predictability between ETFS SP time series from 5th of June 2024 to 3rd of September 2024 and 3rd of September 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ETFS SP Biotech price movement. The serial correlation of 0.14 indicates that less than 14.0% of current ETFS SP price fluctuation can be explain by its past prices.
Correlation Coefficient0.14
Spearman Rank Test0.04
Residual Average0.0
Price Variance2.15

ETFS SP Biotech lagged returns against current returns

Autocorrelation, which is ETFS SP etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ETFS SP's etf expected returns. We can calculate the autocorrelation of ETFS SP returns to help us make a trade decision. For example, suppose you find that ETFS SP has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

ETFS SP regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ETFS SP etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ETFS SP etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ETFS SP etf over time.
   Current vs Lagged Prices   
       Timeline  

ETFS SP Lagged Returns

When evaluating ETFS SP's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ETFS SP etf have on its future price. ETFS SP autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ETFS SP autocorrelation shows the relationship between ETFS SP etf current value and its past values and can show if there is a momentum factor associated with investing in ETFS SP Biotech.
   Regressed Prices   
       Timeline  

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in ETFS Etf

ETFS SP financial ratios help investors to determine whether ETFS Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ETFS with respect to the benefits of owning ETFS SP security.